NDC 69437-416

EC-Naprosyn

Naproxen

EC-Naprosyn is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Canton Laboratories. The primary component is Naproxen.

Product ID69437-416_0aa005eb-b5a2-4f9b-9fa8-0c543a7752b3
NDC69437-416
Product TypeHuman Prescription Drug
Proprietary NameEC-Naprosyn
Generic NameNaproxen
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2016-06-01
Marketing CategoryNDA / NDA
Application NumberNDA020067
Labeler NameCanton Laboratories
Substance NameNAPROXEN
Active Ingredient Strength500 mg/1
Pharm ClassesCyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 69437-416-01

100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (69437-416-01)
Marketing Start Date2016-06-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69437-416-01 [69437041601]

EC-Naprosyn TABLET, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA020067
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-06-01

Drug Details

Active Ingredients

IngredientStrength
NAPROXEN500 mg/1

OpenFDA Data

SPL SET ID:8bff5df5-d856-4237-b6a8-ae445b454844
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 849438
  • 835560
  • 105899
  • 849431
  • 603103
  • 311913
  • 311915
  • 198014
  • 207093
  • 608793
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • UPC Code
  • 0369437316017
  • NUI Code
  • N0000000160
  • N0000175722
  • N0000175721
  • Pharmacological Class

    • Cyclooxygenase Inhibitors [MoA]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]

    NDC Crossover Matching brand name "EC-Naprosyn" or generic name "Naproxen"

    NDCBrand NameGeneric Name
    0004-6415EC-Naprosynnaproxen
    69437-415EC-NaprosynEC-Naprosyn
    69437-416EC-NaprosynEC-Naprosyn
    0363-9609BACK AND MUSCLE PAINNAPROXEN
    0121-0899NaprosynNaproxen
    0121-1798NaprosynNaproxen
    0121-2697NaprosynNaproxen
    0054-3630NaproxenNaproxen
    0093-1005NaproxenNaproxen
    0093-1006NaproxenNaproxen
    0143-1346NaproxenNaproxen
    0143-1347NaproxenNaproxen
    0143-1348NaproxenNaproxen
    0179-1978NaproxenNaproxen
    0440-1852NaproxenNaproxen
    0440-7852NaproxenNaproxen
    0615-1504NaproxenNaproxen
    0615-3562NaproxenNaproxen
    0615-3563NaproxenNaproxen
    0615-7709NaproxenNaproxen
    0615-7892NaproxenNaproxen
    0615-8094NaproxenNaproxen
    10544-010NaproxenNaproxen
    10544-016NaproxenNaproxen
    10544-019NaproxenNaproxen
    10544-044NaproxenNaproxen
    10544-061NaproxenNaproxen
    10544-111NAPROXENNAPROXEN
    10544-277NaproxenNaproxen
    10544-278NaproxenNaproxen
    10544-920NaproxenNaproxen
    10544-922NaproxenNaproxen
    10544-939NaproxenNaproxen
    12634-498NaproxenNaproxen
    12634-684NaproxenNaproxen
    21695-084NaproxenNaproxen
    21695-085NaproxenNaproxen

    Trademark Results [EC-Naprosyn]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    EC-NAPROSYN
    EC-NAPROSYN
    74405354 1920671 Dead/Cancelled
    SYNTEX PUERTO RICO, INC.
    1993-06-18
    EC-NAPROSYN
    EC-NAPROSYN
    74401683 1920670 Live/Registered
    ATNAHS PHARMA US LIMITED
    1993-06-14

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.